Entecavir Therapy for up to 96 Weeks in Patients With HBeAg-Positive Chronic Hepatitis B
- 1 November 2007
- journal article
- research article
- Published by Elsevier BV in Gastroenterology
- Vol. 133 (5), 1437-1444
- https://doi.org/10.1053/j.gastro.2007.08.025
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- Chronic hepatitis BHepatology, 2007
- Predicting Cirrhosis Risk Based on the Level of Circulating Hepatitis B Viral LoadGastroenterology, 2006
- Risk of Hepatocellular Carcinoma Across a Biological Gradient of Serum Hepatitis B Virus DNA LevelJAMA, 2006
- Asian‐Pacific consensus statement on the management of chronic hepatitis B: a 2005 updateLiver International, 2005
- Hepatitis B Virus Genotype and DNA Level and Hepatocellular Carcinoma: A Prospective Study in MenJNCI Journal of the National Cancer Institute, 2005
- Hepatitis B Virus Infection — Natural History and Clinical ConsequencesNew England Journal of Medicine, 2004
- Viral hepatitis BThe Lancet, 2003
- Management of chronic hepatitis BJournal of Hepatology, 2003
- Management of hepatitis B: 2000—Summary of a workshopGastroenterology, 2001
- Hepatitis B Virus InfectionNew England Journal of Medicine, 1997